ABVC BioPharma(us:ABVC)
1.06
+23.26%
Updated on 2025-03-31
Open:0.8680
Close:1.06
High:1.09
Low:0.8500
Prev Close:0.8600
Volume:821358.00
Turnover:804807.25
Turnover Ratio:6.33%
Shares:12.98M
MarketCap:13.75M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 13 | 220402 | 1.83% | 5 | 2 | 3 |
| 2024-03-31 | 10 | 254469 | 2.38% | 2 | 4 | 2 |
| 2023-12-31 | 10 | 110720 | 1.39% | 1 | 3 | 3 |
| 2023-09-30 | 12 | 76799 | 1.59% | 3 | 3 | 5 |
| 2023-06-30 | 11 | 58851 | 0.18% | 2 | 2 | 4 |
| 2023-03-31 | 11 | 661135 | 2.00% | 2 | 4 | 3 |
| 2022-12-31 | 13 | 603148 | 1.84% | 2 | 3 | 7 |
| 2022-09-30 | 12 | 650621 | 1.99% | 7 | 2 | 2 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Chase Investment Counsel Corp | 178377 | 1.67% | 178377 | |
| 2024-03-31 | Vanguard Group Inc | 46947 | 0.44% | 19700 | 72.30% |
| 2024-03-31 | Geode Capital Management, Llc | 22000 | 0.21% | 2520 | 12.94% |
| 2024-03-31 | Bank Of America Corp /De/ | 4440 | 0.04% | 4440 | |
| 2024-03-31 | Tower Research Capital Llc (Trc) | 2520 | 0.02% | 1942 | 335.99% |
| 2024-03-31 | Spotlight Asset Group, Inc. | 100 | 0.00% | 0 | |
| 2024-03-31 | Wells Fargo & Company/Mn | 48 | 0.00% | 28 | 140.00% |
| 2024-03-31 | Royal Bank Of Canada | 37 | 0.00% | 0 | |
| 2024-03-31 | Citadel Advisors Llc | 0 | -27158 | ||
| 2024-03-31 | Renaissance Technologies Llc | 0 | -36100 |
About
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
Address:44370 Old Warm Springs Boulevard
Website:http://www.abvcpharma.com
Market Movers